Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 8/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 6/20 | 1.00 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL28094444 | 0.96 | GSK3B (0.92) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL31557731 | 0.86 | PTPN1 (0.75) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL26135918 | 0.83 | MMP1 (0.76) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL29987081 | 0.83 | PTPN1 (0.75) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL30989548 | 0.82 | GSK3B (0.69) | GSK3BPTPN1CES2 | |
| SCHEMBL205280 | 0.82 | GSK3B (0.80) | GSK3BPTPN1HDAC1HDAC8 | |
| SCHEMBL2074662 | 0.81 | PTPN1 (0.68) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL1360049 | 0.81 | PTPN1 (0.68) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL11095198 | 0.81 | PTPN1 (0.67) | GSK3BPTPN1CES2CES1MMP1 | |
| SCHEMBL4330199 | 0.81 | PTPN1 (0.65) | GSK3BPTPN1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 775 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509819-B2 | Micro-nano structure-based super-hydrophobic fabric and preparation method therefor | SOOCHOW UNIVERSITY (CN) | 2025-12-30 | — | — | US | claimed |
| CN-120081843-A | Fluorescent probe for quantitatively detecting NO in exhaled breath, and preparation method and application thereof | 阜阳师范大学 | 2025-06-03 | — | — | CN | claimed |
| CN-118930487-A | 1,3, 5-Trisubstituted pyrazole compound and preparation method thereof | 赣南师范大学 | 2024-11-12 | — | — | CN | claimed |
| EP-3959200-B1 | NEW TRIAZOLE AND TRIAZOLOTHIADIAZINE DERIVATIVES EXERTING CYTOTOXIC AND APOPTOTIC EFFECTS ON A549 CELLS THROUGH AKT INHIBITION | ANADOLU UNIV (TR) | 2024-03-20 | — | — | EP | claimed |
| US-20230416977-A1 | MICRO-NANO STRUCTURE-BASED SUPER-HYDROPHOBIC FABRIC AND PREPARATION METHOD THEREFOR | SOOCHOW UNIVERSITY (CN) | 2023-12-28 | — | — | US | claimed |
| EP-3958980-B1 | TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER | ANADOLU UNIV (TR) | 2023-11-15 | — | — | EP | claimed |
| CN-115785189-B | 5 alpha, 8 alpha-peroxosterol-17-phenylthiazole derivative and synthetic method and application thereof | 齐齐哈尔医学院 | 2023-08-25 | — | — | CN | claimed |
| CN-115852684-A | Cotton fabric dyeing method | 绍兴市上虞丰达染整有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-115785189-A | 5 alpha, 8 alpha-peroxysterol-17-phenylthiazole derivative and synthetic method and application thereof | 齐齐哈尔医学院 | 2023-03-14 | — | — | CN | claimed |
| WO-2022165777-A1 | MICRO-NANO STRUCTURE-BASED SUPER-HYDROPHOBIC FABRIC AND PREPARATION METHOD THEREFOR | 苏州大学 | 2022-08-11 | — | — | WO | claimed |
| CN-112878053-B | Micro-nano structure based super-hydrophobic fabric and preparation method thereof | 苏州大学 | 2022-03-15 | — | — | CN | claimed |
| WO-2021257020-A1 | TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER | ANADOLU ÜNİVERSİTESİ (TR) | 2021-12-23 | — | — | WO | claimed |
| CN-113234066-A | Propiconazole-like compound and preparation method and application thereof | 浙江工业大学 | 2021-08-10 | — | — | CN | claimed |
| US-20260098036-A1 | 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2026-04-09 | — | — | US | disclosed |
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | UNIV DE VELENCIA (ES) | 2026-03-12 | — | — | US | disclosed |
| US-12522594-B2 | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2026-01-13 | — | — | US | disclosed |
| US-4265898-A | ANTICOAGULANTS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-05-05 | — | — | US | disclosed |
| EP-0005783-A1 | Imidazo (2.1-b)-(1.3.4)-thiadiazoles, process for their preparation and their use in medicaments | BAYER AG (DE) | 1979-12-12 | — | — | EP | disclosed |
| US-4143148-A | ANTI-ULCER THIAZOLINE DERIVATIVES | JOHN WYETH & BROTHER LIMITED (GB) | 1979-03-06 | — | — | US | disclosed |
| US-3965181-A | Tricyclic pharmacological agents, intermediates and methods of making | SYNTEX (U.S.A.) INC. (US) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098036-A1 | 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER | AHR, CBR1, CNR1 | GSK3B 2364/4885PTPN1 1040/4885CES2 994/4885 |
| US-12509819-B2 | Micro-nano structure-based super-hydrophobic fabric and preparation method therefor | KIT, MYB, MAST1 | GSK3B 1838/4885PTPN1 1118/4885CES2 281/4885 |
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | IL1A, IL6, IL1B | GSK3B 3354/4885PTPN1 1200/4885CES2 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.